Danas Klimavicius

Danas Klimavicius

Auto-generated profile, based on publicly available information

Danas Klimavicius

Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, 10257 Vilnius, Lithuania

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDanas Klimavicius
Danas Klimavicius
DRDominik Rafalski
Dominik Rafalski
DSDalia Smalakyte
Dalia Smalakyte
ARAudroe Ruksenaite
Audroe Ruksenaite
GSGiedrius Sasnauskas
Giedrius Sasnauskas
GTGintautas Tamulaitis
Gintautas Tamulaitis
Prokaryotic antiviral type III CRISPR-Cas and CBASS systems use cyclic nucleotides as second messengers to activate diverse effector proteins. Whereas CBASS signaling typically triggers abortive infection, type III CRISPR-Cas signaling is tightly regulated through controlled signal production and degradation. Here, we define the molecular mechanism of the CRISPR-associated Csx15 protein family and demonstrate that Csx15 functions as a broad specificity ring nuclease capable of degrading cyclic nucleotide signals from both CRISPR-Cas and CBASS pathways. Structural and biochemical analyses reveal that Csx15 adopts diverse oligomeric states and undergoes ligand-induced conformational transitions that promote filament assembly required for catalytic activity, analogous to filament-forming SAVED-domain effectors. Finally, we provide evidence that Csx15 is a close relative of SAVED domains suggesting that Csx15-like proteins may have also contributed to the evolution of CBASS cyclic nucleotide signaling.